BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 16965336)

  • 1. Clusterin expression in primary and metastatic melanoma.
    Busam KJ; Kucukgol D; Eastlake-Wade S; Frosina D; Delgado R; Jungbluth AA
    J Cutan Pathol; 2006 Sep; 33(9):619-23. PubMed ID: 16965336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin D1 expression in melanocytic lesions of the skin.
    Ramirez JA; Guitart J; Rao MS; Diaz LK
    Ann Diagn Pathol; 2005 Aug; 9(4):185-8. PubMed ID: 16084449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sox10: a pan-schwannian and melanocytic marker.
    Nonaka D; Chiriboga L; Rubin BP
    Am J Surg Pathol; 2008 Sep; 32(9):1291-8. PubMed ID: 18636017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wilms tumor 1 expression present in most melanomas but nearly absent in nevi.
    Perry BN; Cohen C; Govindarajan B; Cotsonis G; Arbiser JL
    Arch Dermatol; 2006 Aug; 142(8):1031-4. PubMed ID: 16924053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sox10 is expressed in primary melanocytic neoplasms of various histologies but not in fibrohistiocytic proliferations and histiocytoses.
    Shin J; Vincent JG; Cuda JD; Xu H; Kang S; Kim J; Taube JM
    J Am Acad Dermatol; 2012 Oct; 67(4):717-26. PubMed ID: 22325460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. hTERT expression in melanocytic lesions: an immunohistochemical study on paraffin-embedded tissue.
    Fullen DR; Zhu W; Thomas D; Su LD
    J Cutan Pathol; 2005 Nov; 32(10):680-4. PubMed ID: 16293180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of protease-activated receptors 1 and 2 in melanocytic nevi and malignant melanoma.
    Massi D; Naldini A; Ardinghi C; Carraro F; Franchi A; Paglierani M; Tarantini F; Ketabchi S; Cirino G; Hollenberg MD; Geppetti P; Santucci M
    Hum Pathol; 2005 Jun; 36(6):676-85. PubMed ID: 16021575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of S100A6 protein in a broad spectrum of cutaneous tumors using tissue microarrays.
    Fullen DR; Garrisi AJ; Sanders D; Thomas D
    J Cutan Pathol; 2008 Nov; 35 Suppl 2():28-34. PubMed ID: 18201235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of nm23 H-1 protein in conjunctival melanoma and potential precursor lesions.
    Seregard S; Oskarsson M; Spângberg B
    Exp Eye Res; 1999 Dec; 69(6):671-6. PubMed ID: 10620396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression patterns in melanocytic cells: candidate markers for early stage and malignant transformation.
    Meije CB; Hakvoort TB; Swart GW; Westerhof W; Lamers WH; Das PK
    J Pathol; 2002 Jan; 196(1):51-8. PubMed ID: 11748642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue microarray analysis of ezrin, KBA.62, CD166, nestin, and p-Akt in melanoma versus banal and atypical nevi, and nonmelanocytic lesions.
    Shanesmith RP; Smart C; Cassarino DS
    Am J Dermatopathol; 2011 Oct; 33(7):663-8. PubMed ID: 21915031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nestin expression in cutaneous melanomas and melanocytic nevi.
    Brychtova S; Fiuraskova M; Hlobilková A; Brychta T; Hirnak J
    J Cutan Pathol; 2007 May; 34(5):370-5. PubMed ID: 17448190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear expression of the antiapoptotic protein survivin in malignant melanoma.
    Ding Y; Prieto VG; Zhang PS; Rosenthal S; Smith KJ; Skelton HG; Diwan AH
    Cancer; 2006 Mar; 106(5):1123-9. PubMed ID: 16456815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.
    Boyd AS; Shakhtour B; Shyr Y
    J Am Acad Dermatol; 2008 May; 58(5):750-4. PubMed ID: 18249467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of N-cadherin distinguishes a subset of metastasizing desmoplastic melanomas.
    Attis MG; Burchette JL; Selim MA; Pham T; Soler AP
    Hum Pathol; 2006 Jul; 37(7):899-905. PubMed ID: 16784991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of heat shock protein 105 and 70 in malignant melanoma and benign melanocytic nevi.
    Park HS; Park CH; Choi BR; Lim MS; Heo SH; Kim CH; Kang SG; Whang KU; Cho MK
    J Cutan Pathol; 2009 May; 36(5):511-6. PubMed ID: 19476517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different expression of lysosome-associated membrane protein-1 in human melanomas and benign melanocytic lesions.
    Kuźbicki L; Gajo B; Chwirot BW
    Melanoma Res; 2006 Jun; 16(3):235-43. PubMed ID: 16718270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of c-kit (CD117) in Spitz nevus and malignant melanoma.
    Isabel Zhu Y; Fitzpatrick JE
    J Cutan Pathol; 2006 Jan; 33(1):33-7. PubMed ID: 16441409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclooxygenase-2 (COX-2): first immunohistochemical marker distinguishing early cutaneous melanomas from benign melanocytic skin tumours.
    Chwirot BW; Kuźbicki Ł
    Melanoma Res; 2007 Jun; 17(3):139-45. PubMed ID: 17505259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma.
    Busam KJ; Chen YT; Old LJ; Stockert E; Iversen K; Coplan KA; Rosai J; Barnhill RL; Jungbluth AA
    Am J Surg Pathol; 1998 Aug; 22(8):976-82. PubMed ID: 9706977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.